10-DEBC	10-[4’-(N,N-Diethylamino)butyl]-2-chlorophenoxazine hydrochloride
Ach	acetylcholine
ADSHE	autosomal dominant sleep-related hypermotor epilepsy
Akt	protein kinase B
AMPA	amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid
ANOVA	analysis of variance
AUC	area under curve value
CBX	carbenoxolone
CHRNA2	cholinergic receptor nicotinic alpha 2 subunit
CHRNA4	cholinergic receptor nicotinic alpha 4 subunit
CHRNB2	cholinergic receptor nicotinic beta 2 subunit
CRH	corticotropin releasing hormone
Cx43	connexin43
DEPDC5	DEP domain containing 5, GATOR1 subcomplex subunit
DIV	after culture days
EEG	electroencephalogram
Erk	extracellular signal-regulated kinase
FCHK-MRS	Ca2+-free with 100 mM K+ containing modified Ringer’s solution
fDMEM	Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum
FR180204	5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
HK-fDMEM	Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum plus 4.6 mM KCl
KCC	K+/2Cl- cotransporter
KCNT1	potassium sodium-activated channel subfamily T member 1
MANOVA	multivariate analysis of variance
MAPK	mitogen-activated protein kinase
MDTN	mediodorsal thalamic nucleus
MK-fDMEM	Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum plus 2.1 mM KCl and 2.5 mM NaCl
MRS	modified Ringer’s solution
mTOR	mammalian target of rapamycin
nAChR	nicotinic acetylcholine receptor
N-fDMEM	Dulbecco’s modified Eagle’s medium containing 10% fetal calf serum plus 4.6 mM NaCl
OFC	orbitofrontal cortex
pAkt	phosphorylated protein kinase B
pErk	phosphorylated extracellular signal-regulated kinase
PI3K	phosphoinositide 3-kinase
RJR2403	(E)-N-Methyl-4-(3-pyridinyl)-3-buten-1-amine oxalate
RTN	reticular thalamic nucleus
S286L-TG	bearing S286L-mutation in rat Chrna4 gene transgenic rat
STN	subthalamic nucleus
TSC	tuberous sclerosis complex
UHPLC	ultra-high-performance liquid chromatograph